These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11823467)

  • 1. Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen.
    Schwartz JA; Zhong L; Deighton-Collins S; Zhao C; Skafar DF
    J Biol Chem; 2002 Apr; 277(15):13202-9. PubMed ID: 11823467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.
    Zhao C; Koide A; Abrams J; Deighton-Collins S; Martinez A; Schwartz JA; Koide S; Skafar DF
    J Biol Chem; 2003 Jul; 278(29):27278-86. PubMed ID: 12736255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen.
    Danielian PS; White R; Hoare SA; Fawell SE; Parker MG
    Mol Endocrinol; 1993 Feb; 7(2):232-40. PubMed ID: 8469236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the human estrogen receptor-alpha using targeted mutagenesis.
    Skafar DF; Koide S
    Mol Cell Endocrinol; 2006 Feb; 246(1-2):83-90. PubMed ID: 16442702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
    Greschik H; Flaig R; Renaud JP; Moras D
    J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K; Thu N; Saville B; Safe S
    Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The F domain of estrogen receptor α is involved in species-specific, tamoxifen-mediated transactivation.
    Arao Y; Korach KS
    J Biol Chem; 2018 Jun; 293(22):8495-8507. PubMed ID: 29632071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
    Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
    Métivier R; Penot G; Flouriot G; Pakdel F
    Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.
    Mahfoudi A; Roulet E; Dauvois S; Parker MG; Wahli W
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4206-10. PubMed ID: 7753783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast.
    Wrenn CK; Katzenellenbogen BS
    J Biol Chem; 1993 Nov; 268(32):24089-98. PubMed ID: 8226955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells.
    Rousseau C; Pettersson F; Couture MC; Paquin A; Galipeau J; Mader S; Miller WH
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):1-14. PubMed ID: 12943740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
    J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
    Pakdel F; Reese JC; Katzenellenbogen BS
    Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
    Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
    Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding.
    Ekena K; Weis KE; Katzenellenbogen JA; Katzenellenbogen BS
    J Biol Chem; 1996 Aug; 271(33):20053-9. PubMed ID: 8702724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.